The Pacific Coast highway (PCH) reopened Monday morning after being closed for nearly a month due to the devastating Palisades Fire. The route now has one lane in each direction and limited speed ...
SpecHLA reconstructs entire diploid sequences of HLA genes and infers LOH events. It supports HLA-A, -B, -C, -DPA1, -DPB1, -DQA1, -DQB1, and -DRB1 genes. Also, it ...
The New Zealand government is donating 6000 doses of the Boostrix vaccine to Samoa to combat whooping cough, the Samoa government says. A whooping cough outbreak was declared in Samoa last November.
But you want to avoid the really big losses like the plague. So consider, for a moment, the misfortune of Pacific Biosciences of California, Inc. (NASDAQ:PACB) investors who have held the stock for ...
Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.
The M_zebra_GT3a reference was created using a combination of PacBio HiFi reads and Bionano molecules ... Samples across all runs were sequenced on a NovaSeq 6000 instrument using v1.5 chemistry. Note ...
Welcome to the Department of Biosciences. The department delivers innovative, TEF Gold standard teaching and research in subjects including biomedical science, microbiology, biochemistry, pharmacology ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The company is known for pioneering DNA sequencing. Chris Smith, CEO of oncology diagnostic company NeoGenomics Inc., is getting a seat on the board of Pacific Biosciences of California Inc ...
In collaboration with the University of Washington and the Undiagnosed Diseases Network (UDN), the study applied PacBio’s state-of-the-art Revio™ sequencing system to integrate long-read genomic, ...
Pacific Biosciences of California has a 12-month low of $1.16 and a 12-month high of $7.40. The company has a current ratio of 9.74, a quick ratio of 8.64 and a debt-to-equity ratio of 1.97.